ENANTIOMERS OF 6-((4-CHLORO-PHENYL)-HYDROXY-( 3-METHYL-3H-IMIDAZOL-4-YL)-METH YL)4-(3-(3-HYDROXY-3-METHYL-BUT - 1-YNYL)-PHENYL)-1-METHYL-1H-QUI NOLIN-2-ONE AND SALTS THEREOF, USEFUL IN THE TREATMENT OF CANCER
Details for Australian Patent Application No. 2002324817 (hide)
International Classifications
Event Publications
16 January 2003 Complete Application Filed
Priority application(s): 60/315,740 29.08.01 US
5 June 2003 Application Open to Public Inspection
Published as AU-A-2002324817
10 June 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002324818-WICKING METHODS AND STRUCTURES FOR USE IN SAMPLING BODILY FLUIDS
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser